Patent · US Active

Methods for treating Parkinson's disease

US11001891B2 · kind B2 · utility

0Cited by

5References

16Claims

0Family size

Assignee

BERG COMPANIES, INC. · US

Inventors

Niven Rajin Narain · Cambridge, US
Rangaprasad Sarangarajan · Boylston, US
Vivek K. Vishnudas · Bedford, US
Paula Patricia Narain · Cambridge, US
Jeremy Chaufty · Holliston, US
Stephane Gesta · Arlington, US
Reinhard Roessler · Cambridge, US

Key dates

Filing date	Nov 14, 2017
Grant date	May 11, 2021
Priority date	—
Expiry date	Nov 14, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides methods for treating Parkinson's Disease (PD), e.g., PD associated with a genetic mutation in a glucocerebrosidase (GBA) gene or a leucine rich repeat kinase 2 (LRRK2) gene. The methods comprise administering to the subject a modulator, e.g., an inhibitor, of p53-inducible gene 3 (PIG3).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.